Novo Nordisk Long Term Deferred Assets (Quarterly) Trends

Novo Nordisk A/S (NVO)

60.40 -1.93 (-3.10%) USD | NYSE | Jan 20, 09:48

View Long Term Deferred Assets (Quarterly) for NVO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Ascendis Pharma A/S	--
Evaxion AS	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Omeros Corp.	--
Viking Therapeutics, Inc.	Upgrade